Does Molina Healthcare Cover Mounjaro?
The verdict
Conditional on most plans
Molina Healthcare covers Mounjaro for type 2 diabetes across its Medicaid managed-care plans at nominal $0-$4 Medicaid cost-share with prior authorization. Off-label weight-loss use is explicitly not covered — Molina Medicaid excludes GLP-1s for obesity in most states. The weight-loss tirzepatide is Zepbound, with separate coverage. This is the clearest T2D-covered / weight-loss-excluded split in the Mounjaro cluster.
Coverage is set by your specific plan and formulary. This is a research summary — always confirm with Molina Healthcare using your member ID.
Key facts
Molina Healthcare covers Mounjaro for type 2 diabetes at $0-$4 Medicaid nominal copay — the lowest cost-share of any major insurer in this cluster — because Medicaid cost-sharing is capped at nominal amounts.
Molina Healthcare Medicaid plan documentation; CMS Medicaid copay rules
Molina Medicaid explicitly excludes GLP-1 receptor agonists for obesity in most states. Michigan Medicaid is an exception for AOM weight-loss coverage — but that applies to Wegovy/Zepbound, not Mounjaro.
Molina Healthcare state-specific Medicaid PDL documentation
Mounjaro (tirzepatide) is FDA-approved for glycemic control in adults with type 2 diabetes only. The weight-loss tirzepatide product is Zepbound — a separate FDA approval, separate coverage.
FDA, Mounjaro (tirzepatide) Prescribing Information, 2023
Medicare vs. commercial coverage
Whether Molina Healthcare covers Mounjaro depends heavily on which kind of plan you hold. They follow completely different rules — here's each one, side by side.
Medicare
Part D & Advantage plans
Molina Medicare Advantage-PD plans cover Mounjaro for type 2 diabetes only — not weight loss — with prior authorization. The 2026 Part D out-of-pocket cap is $2,100; most continuous users reach it within 2-3 months and pay $0 thereafter. The IRA-negotiated Medicare MFN price of $245/month begins mid-2026. Mounjaro is NOT in the 2026 Medicare GLP-1 Bridge, which covers weight-loss-approved products only. The Lilly savings card is not usable by Medicare or Medicaid beneficiaries.
Commercial / Employer
Group & marketplace plans
Molina has a limited commercial and ACA presence. Where commercial coverage is offered, Mounjaro is covered for type 2 diabetes with prior authorization; weight-loss use is excluded. ACA/Individual: covered for T2D with PA where offered; weight-loss GLP-1s commonly excluded. Medicaid (primary LOB): Mounjaro covered across Molina Medicaid MCO states for T2D with PA and metformin step therapy at $0-$4 nominal Medicaid copay. GLP-1s for obesity are explicitly not covered in most Molina Medicaid states. PDL placement varies by state — verify on your state-specific Molina preferred drug list. The Lilly savings card is not available to Medicaid beneficiaries.
The 4 boxes you must tick to get approved
Commercial plans that will consider Mounjaro require prior authorization. Check off what applies to you to see how close you are — this is a guide, not a guarantee of approval.
Meet all 4 and you have a documented case for approval. Missing any one is the most common reason requests are denied.
Your cost, three ways
What Mounjaro actually costs you swings enormously depending on how it's covered. Here's the realistic range.
Paying cash
Approximately $1,300–$1,560/month retail (WAC ~$1,080). Lilly savings card: $499/month for commercially insured without coverage (max $647/month; up to 13 fills; expires 12/31/2026). Not available to Molina Medicaid or Medicare beneficiaries.
List price with no coverage — before any manufacturer savings card.
With coverage
Molina Medicaid (primary): $0-$4 nominal copay per state PDL for covered T2D use. Molina Medicare Advantage-PD: 25% coinsurance after deductible until the $2,100 OOP cap; most continuous users reach the cap in 2-3 months. MFN price $245/month mid-2026 for Medicare enrollees.
Typical monthly copay once prior authorization is approved.
All figures are estimates; actual cost-share varies by state PDL and plan. Verify on your state-specific Molina formulary or member services.
Check YOUR exact coverage in 3 steps
General answers only get you so far. Here's how to confirm your own plan's decision in a few minutes.
- 1
Look up Mounjaro on your state-specific Molina preferred drug list
Visit molinahealthcare.com and navigate to your state's plan page. Find the preferred drug list (PDL) or formulary for your Medicaid or Medicare plan. Search for 'Mounjaro' or 'tirzepatide' and confirm it is listed for diabetes (ICD-10 E11.x). PDL placement and copay vary by state — do not assume national uniformity.
- 2
Work with your prescriber on the PA and state-PDL step documentation
Your prescriber must document your confirmed T2D diagnosis and prior use of metformin. Some state Molina Medicaid PDLs also require A1c documentation — your prescriber should check the state-specific PA criteria. Submit through your prescriber's office or Molina's provider portal.
- 3
Call Molina member services to confirm T2D coverage and weight-loss exclusion
Call the number on your Molina card. Ask: Is Mounjaro covered for type 2 diabetes on my state plan? What is the copay? Is Mounjaro covered for weight loss? (Answer: No — Molina Medicaid explicitly excludes GLP-1s for obesity in most states. The weight-loss tirzepatide is Zepbound, covered separately.)
Options if Molina Healthcare won't cover Mounjaro
A denial isn't the end of the road. These are the paths people commonly explore next — discuss any of them with your prescriber.
Ozempic (semaglutide)
FDA-approved for type 2 diabetes. Commonly covered on Molina Medicaid PDLs with prior authorization at nominal cost-share.
Trulicity (dulaglutide)
FDA-approved for T2D. GLP-1 alternative frequently on Molina Medicaid PDLs with lower list price than Mounjaro.
Metformin (generic)
First-line oral therapy for T2D, covered at very low or no cost on virtually all Molina Medicaid plans. Required as step therapy before GLP-1 approval.
Zepbound (tirzepatide) — weight loss only
Same molecule as Mounjaro (tirzepatide) but FDA-approved for chronic weight management — not diabetes. Molina Medicaid explicitly excludes GLP-1s for obesity in most states. Michigan Medicaid is a noted exception for weight-loss AOM coverage, but that applies to Wegovy/Zepbound — never to Mounjaro.
These options are listed for information only — your own clinician decides what is appropriate for you.
❓Frequently Asked Questions
No. Molina Healthcare explicitly does not cover GLP-1s for obesity (weight loss) in most of its Medicaid states. Mounjaro is FDA-approved for type 2 diabetes only. Off-label weight-loss requests are denied. Where a state Medicaid does cover a weight-loss GLP-1 (e.g., Michigan AOM benefit), that applies to Wegovy or Zepbound — never to Mounjaro.
For covered type 2 diabetes use, Molina Medicaid cost-share is typically $0-$4 per fill — the standard nominal Medicaid copay structure. Exact copay varies by state PDL. The Lilly Mounjaro savings card is not available to Medicaid beneficiaries. Verify your state-specific copay on your Molina plan's preferred drug list or by calling member services.
Both Molina and Wellcare (Centene) are Medicaid and Medicare-focused carriers that cover Mounjaro for T2D with PA and exclude weight-loss use. The key distinction: Wellcare is more Part D-forward, making the $2,100 OOP cap the central cost story. Molina is Medicaid-forward, where the $0-$4 state-PDL copay structure is the operative cost. Both exclude GLP-1s for obesity.
Molina covers Mounjaro for type 2 diabetes across its Medicaid MCO states with prior authorization, but PDL placement and specific criteria vary by state. Molina operates in California, Florida, Idaho, Illinois, Michigan, Mississippi, New Mexico, New York, Ohio, South Carolina, Texas, Utah, Virginia, Washington, and Wisconsin. Verify coverage on your state-specific Molina PDL or member services.
No. The Lilly Mounjaro Savings Card is explicitly unavailable to Medicaid, Medicare Part D, Medicare Advantage, Medigap, DoD, VA, and TRICARE beneficiaries — and Molina's primary membership is Medicaid and Medicare. If you have a Molina commercial plan (rare), the card may be available. Verify your specific plan type with Molina member services.
Related Articles
Does Molina Healthcare Cover Vyvanse? 2026
Molina covers Vyvanse for ADHD and binge-eating disorder with PA — generic preferred, brand non-preferred. One stimulant at a time rule; 70 mg/day QL.
Read moreDoes Blue Cross Blue Shield of Michigan Cover Mounjaro? | Curex
BCBS of Michigan covers Mounjaro for type 2 diabetes with PA, not weight loss. Zepbound weight-loss exclusion upheld by MI DIFS in 2025.
Read moreDoes Blue Cross Blue Shield of Minnesota Cover Mounjaro? 2026 | Curex
BCBS of Minnesota covers Mounjaro for type 2 diabetes with PA — not weight loss. MN Medicaid covers weight-loss GLP-1s for Zepbound, not Mounjaro.
Read moreDoes Molina Healthcare Cover Ozempic? 2026 Guide | Curex
Molina Medicaid covers Ozempic for T2D at $0–$4 copay — explicitly excluded for weight loss. State PDL variations, PA steps, and 2026 cost facts.
Read moreDoes Blue Cross Blue Shield Cover Mounjaro? 2026 Guide | Curex
BCBS covers Mounjaro for type 2 diabetes with prior authorization — not for weight loss. The weight-loss tirzepatide is Zepbound, with separate coverage.
Read moreDoes Blue Cross Blue Shield of Arizona Cover Mounjaro? | Curex
BCBS of Arizona covers Mounjaro for type 2 diabetes with prior auth — not weight loss. AZ Medicaid covers Wegovy for weight loss, but not Mounjaro.
Read moreInsurance covers Mounjaro only for diabetes — for weight loss, here's a path that skips insurance
Molina Medicaid explicitly excludes GLP-1s for obesity in most states, and Mounjaro is diabetes-only everywhere. For patients seeking tirzepatide for weight loss without a diabetes diagnosis, compounded tirzepatide from $149/mo (and compounded semaglutide from $49/mo) is available at getcurex.com/cl/glp — no insurance required, no prior authorization. This is compounded tirzepatide and is not the same medication as Mounjaro or Zepbound. Prescription required, subject to provider review.
- Medication + free shipping
- 24/7 provider access
- Medical intake & prescription review
Compounded semaglutide and tirzepatide are not the same medications as Mounjaro and are not branded or FDA-approved products. Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.
This content is for informational purposes only and does not constitute medical, financial, or insurance advice. Coverage rules, prior-authorization criteria, and copay amounts change frequently and vary by plan, formulary tier, and effective date — always verify current benefits directly with Molina Healthcare before making any decision. Consult a licensed healthcare provider and your plan administrator for guidance specific to your situation. Curex offers compounded semaglutide and tirzepatide, which are not the same medications as Mounjaro and are not branded or FDA-approved products; prescription required, subject to provider review. Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.